267 related articles for article (PubMed ID: 27627627)
21. Novel 2-(2-benzylidenehydrazinyl)benzo[d]thiazole as potential antitubercular agents.
Bairwa VK; Telvekar VN
Comb Chem High Throughput Screen; 2013 Mar; 16(3):244-7. PubMed ID: 23176058
[TBL] [Abstract][Full Text] [Related]
22. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Papadopoulou MV; Bloomer WD; Rosenzweig HS
Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
[TBL] [Abstract][Full Text] [Related]
23. Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels.
O'Malley T; Alling T; Early JV; Wescott HA; Kumar A; Moraski GC; Miller MJ; Masquelin T; Hipskind PA; Parish T
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632008
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
Karale UB; Krishna VS; Krishna EV; Choudhari AS; Shukla M; Gaikwad VR; Mahizhaveni B; Chopra S; Misra S; Sarkar D; Sriram D; Dusthackeer VNA; Rode HB
Eur J Med Chem; 2019 Sep; 178():315-328. PubMed ID: 31195172
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
[TBL] [Abstract][Full Text] [Related]
28. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
[TBL] [Abstract][Full Text] [Related]
29. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
Desai NC; Trivedi AR; Somani HC; Bhatt KA
Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents.
Kang S; Kim YM; Jeon H; Park S; Seo MJ; Lee S; Park D; Nam J; Lee S; Nam K; Kim S; Kim J
Eur J Med Chem; 2017 Aug; 136():420-427. PubMed ID: 28527405
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
34. Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties.
Liu R; Marshall K; Ma R; Lien Thi Pham K; Shetye G; Liu Z; Cho S; Jeong H; Franzblau SG; Moraski GC; Miller MJ
Bioorg Chem; 2022 Nov; 128():106074. PubMed ID: 35987188
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
36. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK
Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents.
Ran K; Gao C; Deng H; Lei Q; You X; Wang N; Shi Y; Liu Z; Wei W; Peng C; Xiong L; Xiao K; Yu L
Bioorg Med Chem Lett; 2016 Aug; 26(15):3669-74. PubMed ID: 27289321
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.
Abrahams KA; Cox JA; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Fernández R; Alemparte C; Remuiñán MJ; Barros D; Ballell L; Besra GS
PLoS One; 2012; 7(12):e52951. PubMed ID: 23300833
[TBL] [Abstract][Full Text] [Related]
40. Novel anti-tuberculosis agents from MCR libraries.
Dömling A; Achatz S; Beck B
Bioorg Med Chem Lett; 2007 Oct; 17(19):5483-6. PubMed ID: 17720495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
